0000899243-19-024005.txt : 20190920 0000899243-19-024005.hdr.sgml : 20190920 20190920173140 ACCESSION NUMBER: 0000899243-19-024005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190919 FILED AS OF DATE: 20190920 DATE AS OF CHANGE: 20190920 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lee June CENTRAL INDEX KEY: 0001696493 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37609 FILM NUMBER: 191105514 MAIL ADDRESS: STREET 1: C/O MYOKARDIA, INC. STREET 2: 333 ALLERTON AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MyoKardia Inc CENTRAL INDEX KEY: 0001552451 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 455500552 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-741-0900 MAIL ADDRESS: STREET 1: 333 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-09-19 0 0001552451 MyoKardia Inc MYOK 0001696493 Lee June C/O MYOKARDIA, INC. 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 0 1 0 0 EVP, Chief Development Officer Common Stock 2019-09-19 4 M 0 5435 11.95 A 10014 D Common Stock 2019-09-19 4 S 0 5435 57.0844 D 4579 D Stock Option (Right to Buy) 11.95 2019-09-19 4 M 0 5435 0.00 D 2027-01-31 Common Stock 5435 128242 D This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person. Represents the weighted average sale price of the shares sold ranging from $57.00 to $57.22 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. 25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date. /s/ Cynthia Ladd, as Attorney-in-Fact 2019-09-20